Share page on Facebook Share page on Twitter Share page on LinkedIn Home About ICON ICON in Asia Pacific As a leading CRO with a presence in Asia Pacific since 1995, local know-how is our speciality We understand the unique challenges of conducting research in the Asia Pacific region and use our country-specific knowledge to ensure we deliver quality data to our clients on time and within budget. We operate in eleven countries (Australia, China, India, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand), and have the capability and expertise to conduct clinical trials and development projects on both a local, cross-region and global basis and provide the full range of ICON Services. 7,350 Professionals 11 Countries 1995 Year we came to Asia Pacific At ICON, we use our insight and innovation to drive measurable performance improvements. Our operational capability and therapeutic expertise enable us to deliver value and operational excellence in drug development projects, which translates into constantly exceeding client expectations. Why Asia Pacific? A number of factors contribute to Asia Pacific being an excellent location for clinical trials: Regulatory bodies are actively encouraging Multi Regional Clinical Trials Patient access - Two-thirds of the world’s population live in the region Relatively less competition for patients with fewer clinical trials enrolling compared to US & EU High prevalence of certain diseases - diabetes, hepatitis B, cardiovascular, chronic lower respiratory disease, influenza and pneumonia Strong presence of academic institutions and high-quality investigators ICH-GCP guidelines have been adopted for more than 10 years Quality is constantly improving and standards are comparable to western standards Significant progress has been made by some key territories to enforce IPP and implement patent laws Costs are relatively lower in some countries compared to US and EU IN THIS SECTION Company history ICON in Asia Pacific Japan ICON in Latin America Leadership Quality Environmental, Social & Governance ICON and You Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information MEDIA ARTICLE Navigating the regulatory and pharmacovigilance landscape in Asia FACTSHEET The dynamics of drug development in China MEDIA ARTICLE Oncology clinical trials in Asia Pacific Next 1 2 Contact About ICON Results & Reports For Clients Therapeutics Services Insights Innovation Content Preferences Office locations ICON For Patients Volunteers Investigators Jobs & Careers Investors Suppliers News & Events Press Releases Mediakit Events Social Media Dashboard LinkedIn Twitter Facebook Youtube © 2021 ICON plc Disclaimer Privacy Site Cookies